Literature DB >> 15079036

4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain.

R Kalla1, S Glasauer, F Schautzer, N Lehnen, U Büttner, M Strupp, T Brandt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15079036     DOI： 10.1212/01.wnl.0000118287.68294.e5

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  18 in total

1.  Current treatment of vestibular, ocular motor disorders and nystagmus.

Authors:  Michael Strupp; Thomas Brandt
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

Review 2.  Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus.

Authors:  Katharina Feil; Tatiana Bremova; Carolin Muth; Roman Schniepp; Julian Teufel; Michael Strupp
Journal:  Cerebellum       Date:  2016-02       Impact factor: 3.847

3.  Effect of 4-aminopyridine on gravity dependence and neural integrator function in patients with idiopathic downbeat nystagmus.

Authors:  T Sander; A Sprenger; S Marti; T Naumann; D Straumann; C Helmchen
Journal:  J Neurol       Date:  2010-11-06       Impact factor: 4.849

Review 4.  The physiological basis of therapies for cerebellar ataxias.

Authors:  Hiroshi Mitoma; Mario Manto
Journal:  Ther Adv Neurol Disord       Date:  2016-05-20       Impact factor: 6.570

Review 5.  Aminopyridines for the treatment of neurologic disorders.

Authors:  Michael Strupp; Julian Teufel; Andreas Zwergal; Roman Schniepp; Kamran Khodakhah; Katharina Feil
Journal:  Neurol Clin Pract       Date:  2017-02

6.  [Pharmacological treatment of nystagmus].

Authors:  C Pieh-Beisse; W A Lagrèze
Journal:  Ophthalmologe       Date:  2011-02       Impact factor: 1.059

7.  Dalfampridine in patients with downbeat nystagmus--an observational study.

Authors:  Jens Claassen; Katharina Feil; Stanislav Bardins; Julian Teufel; Rainer Spiegel; Roger Kalla; Erich Schneider; Klaus Jahn; Roman Schniepp; Michael Strupp
Journal:  J Neurol       Date:  2013-04-16       Impact factor: 4.849

Review 8.  [Pharmacotherapy of central oculomotor disorders].

Authors:  R Kalla; R Spiegel; J Wagner; N Rettinger; K Jahn; M Strupp
Journal:  Nervenarzt       Date:  2008-12       Impact factor: 1.214

9.  A model-based theory on the origin of downbeat nystagmus.

Authors:  Sarah Marti; Dominik Straumann; Ulrich Büttner; Stefan Glasauer
Journal:  Exp Brain Res       Date:  2008-05-08       Impact factor: 1.972

10.  Consensus paper: management of degenerative cerebellar disorders.

Authors:  W Ilg; A J Bastian; S Boesch; R G Burciu; P Celnik; J Claaßen; K Feil; R Kalla; I Miyai; W Nachbauer; L Schöls; M Strupp; M Synofzik; J Teufel; D Timmann
Journal:  Cerebellum       Date:  2014-04       Impact factor: 3.847
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.